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Background/aim: This study aimed to study the effect of pretreatment transcutaneous electrical acupoint stimulation (TEAS) in
preventing propofol injection-related pain.
Materials and methods: A total of 360 patients who were to undergo elective hysteroscopy surgery were randomly divided into the
following three groups of 120 patients each: control (Group C), sham TEAS (Group F), and TEAS (Group T). Patients in Group C
did not undergo any treatment before surgery; 30 min before the induction of anesthesia, patients in Groups F and T underwent
electrical stimulation of the bilateral LI4-PC6 acupoint. Patients in Group F were subjected to “feeling flow”, while those in Group T were
subjected to “tolerance flow.” The stimulation frequency was 2/100 Hz and the duration of stimulation was 30 min. After the induction
of anesthesia, propofol injection-related pain scores, hemodynamic parameters, and adverse reactions were recorded.
Results: Of the 360 patients, 324 completed the study. There were significant differences among the groups in terms of the incidence
of moderate-to-severe pain. In terms of the four-point scaling method, the end of the radial vein, the cubital vein, and the “back of the
hand” vein differed significantly among the three groups (P = 0.05). Finally, using a numerical rating scale, a significant difference was
observed among the three groups in terms of the pain scores in the different veins.
Conclusions: Pretreatment TEAS effectively reduces the incidence and severity of propofol injection-related pain, the incidence of
postoperative nausea and vomiting, and patient postoperative pain scores.
Key words: Transcutaneous electrical stimulation, propofol, injection pain

1. Introduction
Propofol has the advantages of rapid onset, short duration
of action, rapid recovery, and few side effects. For
these reasons, it is among the most widely used clinical
intravenous anesthetics. However, propofol injectionrelated pain ranked third among the 33 most common
anesthesia-related surgical complications in outpatients
(1,2), corresponding to an incidence of 28% to 90% (3).
In 2011, a metaanalysis showed that more than 60% of
patients experience propofol injection-related pain, some
of which is severe or even unbearable (4). Both foreign and
domestic investigators have suggested many methods of
preventing or mitigating propofol injection-related pain,
including use of a thicker vein, slow injection speed, and
addition of lidocaine. Although many of these methods are
relatively effective, no single reliable and effective method
is widely used.

Transcutaneous electrical acupoint stimulation
(TEAS) represents a combination of transcutaneous
electrical nerve stimulation and traditional acupuncture
(5). The technique directs a specific, low-frequency
pulse current into the body via the skin, producing an
antiinflammatory, analgesic effect. Research has shown
that it can also facilitate sedation (6), promote recovery of
the gastrointestinal tract, regulate the immune system, and
facilitate organ protection. Due to its noninvasive nature,
TEAS has been widely used in clinical practice.
The present study evaluated whether TEAS
pretreatment can reduce the incidence and/or degree of
propofol injection-related pain.
2. Materials and methods
2.1. General information
A total of 360 women were included in the present study.
All were aged 18–65 years and had a body mass index
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ranging from of 18–31 kg/m2, as well as an American
Anesthesiologists Society (ASA) grade of I or II.
Furthermore, all had provided written, informed consent
for elective hysteroscopy or surgical treatment. Patients
with a history of chronic pain syndrome, thrombophlebitis,
neurological disease, forearm or thrombophlebitis
syndrome with acute and chronic pain, severe mental
disease, language barrier, or gastrointestinal ulcers were
excluded from the study, as were patients allergic to lipid
medications, propofol, and/or general anesthetic drugs.
Furthermore, patients with history of abuse of analgesic
and/or sedative substances were also excluded, as were
patients with a surgical incision, surgical scar, or skin
infection at the LI4-PC6 acupoint; a nerve injury in the
upper extremities; or a history of spinal surgery. Patients
were randomly divided into the following three groups of
120 subjects each: control (C), sham TEAS (F), and TEAS
(T).
2.2. Patient treatment
Patients underwent routine preoperative fasting and were
not given any premedication. Thirty minutes before the
induction of anesthesia, during anesthesia preparation, two
of the three groups were given TEAS by an anesthesiologist
who was not involved in the anesthesia itself or the pain
efficacy evaluation. The patients in the control group were
not given any treatment, and a 22-gauge trocar was used
to open their secondary upper main vein. The patients’
blood pressure was measured noninvasively, and they were
monitored using an electrocardiogram (ECG) and pulse
oximetry after entering the operating room. They were
also given oxygen (5 L/min) via a nasal cannula. After their
infusion channel had been connected to the extension
tube, 500 mL of lactated Ringer’s was infused (20 mL/
min) through the channel. After a 30-min pretreatment,
the anesthesiologist instructed the gynecologist to proceed
with preoperative preparation; anesthesia induction was
initiated at the same time. The three groups of patients
received sufentanil (5 µg from the infusion channel) via
a 30-s fast injection using a micropump (speed: 1200
mL/h). After 1% propofol (2 mg/kg) had been injected,
the patients were enquired about their pain every 5 s
until they lost consciousness; pain scores were recorded
at each point. The surgical operation then commenced.
Anesthesia was maintained using a continuous infusion
of propofol (4 mg/kg per hour) and remifentanil (0.1 µg/
kg per minute) via a micropump. If the patient physically
responded to the surgical procedures, an additional
single intravenous injection of propofol (0.5 mg/kg) was
administered. If the heart rate (HR) fell to below 60 bpm
during surgery, the patient received intravenous atropine
(0.5 mg). If the mean arterial pressure (MAP) dropped
below 60 mmHg, intravenous ephedrine (5–10 mg) was
administered. Finally, mask pressure oxygen was provided
if the oxygen saturation (SPO2) fell below 90% (Figure 1).
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2.3. TEAS (Figure 2)
Patients in the sham TEAS group (Group F) were
positioned comfortably; an electrode tab was then pasted
onto their bilateral LI4-PC6 acupoint (1) and connected
to an acupoint nerve stimulator (manufactured in South
Korea). The stimulation strength of the density wave
(2/100 Hz) was increased until the patient could feel it. A
similar protocol was applied in the TEAS group (Group
T): the stimulation intensity of the density wave (2/100
Hz) was increased, and the current flow was gradually
increased until the patients felt uncomfortable.
2.4. Four-point verbal rating scale
The verbal rating scale (VRS) was as follows: 0—no pain,
1—mild pain, 2—moderate pain, 3—severe pain. The VRS
score was determined to be 2 or 3 according to the patient’s
limb response. If there was no obvious physical reaction,
the patient was asked whether she felt pain; she was then
assigned a score of 0 or 1. The four-stage VRS evaluation
method has been widely used to assess propofol injectionrelated pain.
2.5. Dysmenorrhea severity level
The severity of dysmenorrhea was graded as follows: 0—
no dysmenorrhea, 1—mild, 2—moderate, 3—severe.
2.6. Curative effect observation
The main outcome measures were verbal response, facial
expressions, arm withdrawal during propofol injection,
and highest pain score recorded. The secondary outcome
measures were the hemodynamic measurements (blood
pressure, heart rate, pulse oximetry before induction of
anesthesia, and pulse oximetry 1 min after the injection of
propofol). Also recorded were the total amounts of propofol
and remifentanil used, duration of surgery, recovery time to
discontinuation, body movements, respiratory depression
(SPO2 less than 90%), and occurrence of postoperative
nausea, vomiting, and other adverse reactions. The
patient’s pain score was recorded and evaluated after she
had been awake for 30 min. Loss of the eyelash reflex
was regarded as an indicator of unconsciousness during
anesthesia, while opening of the eyes was regarded as the
standard of return to consciousness after surgery.
2.7. Statistical analysis
In 30 preliminary experiments, the incidence of moderateto-severe propofol injection-related pain was reduced
from 80% in the control group to 58% in the TEAS group.
With an α-value of 0.05 and a power of 0.8, each group’s
sample size was 36. Considering that different veins
would be chosen (veins on the hand, radial vein, cubital
vein), and that a small part of the access may drop, we
set each group size as 120 people. All data were analyzed
using SPSS 19.0 (IBM Corp., USA). Data with normal
distribution and homogeneity of variance between the two
groups (according to mean ± standard deviation) were
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Figure 1. Study flow diagram.

Figure 2. Illustration of the LI4-PC6 acupoint.

compared using analysis of variance (ANOVA); the overall
difference was statistically significant data. A pairwise least
significant difference (LSD) comparison method was used
to analyze the data. Data that were not normally distributed
were presented as medians (interquartile range), and the
Kruskal–Wallis H test was used instead. For overall data
that had statistically significant differences among the
groups, a rank pairwise comparison was performed using

the LSD method. Countable data were compared using
either the chi-square test (continuity correction of χ2) or
Fisher’s exact test according to the frequency of the sample
size and the theory of variable number of categories;
pairwise comparison was used for data that had an overall
statistically significant difference. Ratings data were
analyzed using the Kruskal–Wallis H test as well as by LSD
pairwise comparison of rank. Other than in the chi-square
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test, where a pairwise comparison test level of 0.017 was
considered to be statistically significant, P < 0.05 was set as
the significance level.
3. Results
Among the 360 patients, 33 were excluded, including 26
who exhibited abnormal blood pressure as they entered
the surgical theater. These patients had no history of
hypertension, but in the operating room they had a
systolic blood pressure (SBP) greater than 180 mmHg that
showed no improvement after 5 min. The remaining seven
patients who were excluded had refused to participate in
subsequent trials after pretreatment (Figure 3).
In patients with venous access, there were no statistically
significant differences among the three groups of patients
in terms of age, height, weight, ASA classification, degree
of dysmenorrhea, and number of operations (Table 1).
Hemodynamic parameters were compared among
patients, who were divided into three subgroups on the
basis of venous access. In the hand vein subgroup, diastolic
blood pressure (DBP) was significantly different among
the groups after 1 min (P < 0.05); pairwise comparison
results showed that there were significant differences
in DBP between Group C and Group F after 1 min (P
= 0.018). Similarly, SPO2 differed significantly among
the groups after 1 min (P = 0.02); pairwise comparison
showed that the difference between Group C and Group
F was significant (P = 0.018). There was no statistically
significant difference in the remaining variables among
the groups.
In the “end of radial vein” subgroup, there were
significant differences in heart rate among the groups
after 1 min. Pairwise comparison showed that heart rate

differed significantly between Group C and Group T after
1 min (P = 0.015). The remaining variables demonstrated
no significant difference among the groups.
In the cubital vein subgroup, there were statistically
significant differences in SBP among the groups after 1
min (P = 0.006); pairwise comparison showed that the SBP
differed significantly between Group C and Group F after
1 min (P < 0.05). SPO2 also differed significantly among
the groups after 1 min (P = 0.004); pairwise comparison
showed a significant difference between Group 1 and
Group 2 (P = 0.003). The remaining variables showed no
statistically significant difference among the groups (Table
2).
The three groups were also compared in terms of basic
anesthetic conditions. In the hand vein subgroup, there
were significant differences among the groups in terms
of remifentanil dosage (P < 0.05); pairwise comparison
showed significant differences in remifentanil dosage
between Group C and Group F (P = 0.018). None of the
remaining variables were significantly different among the
groups.
In the “end of radial vein” group, there were significant
differences among the groups in terms of propofol dosage
(P < 0.05); pairwise comparison showed that propofol
dosage differed significantly between Group F and Group
T (P = 0.017). None of the remaining variables showed any
significant difference among the groups.
In the cubital vein subgroup, no significant differences
were found among the groups (Table 3).
The three groups were also compared in terms of
restlessness, dysphoria, dizziness, nausea, and vomiting
after surgery. In the hand vein subgroup, there was a
significant difference in the incidence of dysphoria among

Figure 3. Flow of participants through a randomized, double-blind study investigating the efficacy of pretreatment with
transcutaneous electrical acupoint stimulation in the prevention of propofol injection-associated pain.
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Δ DBP

10.40 ± 14.93

135.70 ± 14.24
80.07 ± 9.70
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77.02 ± 10.24
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Δ HR
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8.12 ± 9.69

16.21 ± 8.80

25.14 ± 12.44

134.00 ± 15.15
78.12 ± 9.81
99.00 / 1.00
83.42 ± 13.83
108.86 ± 12.61
61.91 ± 9.28
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75.30 ± 11.93
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7.70 ± 10.21

13.80 ± 8.29
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133.83 ± 11.47
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0.317
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0.082
0.311
0.189
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0.020
0.699

P

7.20 ± 10.29

12.27 ± 10.35

21.62 ± 11.26

135.49 ± 11.69
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64.40 ± 8.29
100.00 / 2.00
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45

5.28 ± 8.70

14.03 ± 8.29

22.08 ± 12.15

133.90 ± 12.73
77.80 ± 9.20
99.00 / 3.00
82.15 ± 13.28
111.83 ± 11.45
63.78 ± 9.13
99.00 / 2.00
76.88 ± 11.43

40

Group F

Group C

Group T

Group C

Group F

End of the radial vein group

Hand vein group

6.93 ± 11.58

14.32 ± 9.50

24.25 ± 13.54

136.18 ± 14.76
78.04 ± 10.11
98.50 / 2.00
80.39 ± 12.85
111.93 ± 11.36
63.71 ± 7.72
99.00 / 2.00
73.46 ± 10.50

28

Group T

0.654

0.582

0.652

0.747
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0.650
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0.266
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8.39 ± 11.34

12.94 ± 11.57

21.61 ± 12.44

136.61 ± 9.28
77.06 ± 11.47
99.00 / 2.00
83.44 ± 15.91
115.00 ± 8.92
64.11 ± 8.78
100.00 / 1.00
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18

Group C

8.06 ± 8.68

17.20 ± 7.13

25.51 ± 11.02

135.31 ± 13.99
79.94 ± 10.15
99.00 / 2.00
82.31 ± 11.40
109.80 ± 9.19
62.74 ± 7.70
99.00 / 2.00
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35

Group F

Cubital vein group

16 / 13 / 5 / 1

17 / 18

56.21 ± 8.08

0.473 9 / 8 / 1 / 0

0.959 9 / 9
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Table 2. The comparison between hemodynamics of different patients whose venous accesses are divided into three groups.

Degree of
19 / 23 / 1 / 0 21 / 18 / 4 / 0 37 / 11 / 4 / 2 0.138 27 / 17 / 1 / 0 28 / 11 / 1 / 0 21 / 5 / 1 / 1
dysmenorrhea
Number of
0/1/0/2
0/1/0/3
0/1/0/4
0.547 0 / 1 / 0 / 2
0/1/0/2
0/1/0/2
operations

20 / 23

0.458 55.38 ± 8.22

9.29 ± 9.93

16.95 ± 11.70

30.38 ± 9.75

135.76 ± 13.26
76.71 ± 10.72
98.00 / 1.00
84.48 ± 16.76
105.38 ± 9.10
59.76 ± 6.82
100.00 / 2.00
75.19 ± 16.31

21

Group T

0/1/0/4

14 / 5 / 2 / 0

10 / 11

0.900

0.294

0.051

0.824
0.465
0.120
0.998
0.006
0.194
0.004
0.954

P

0.977

0.304

0.989

53.40 ± 5.05 0.342

40.14 ± 14.34 35.33 ± 8.50 0.459

21 / 22

53.78 ± 6.94

0.742 37.89 ± 7.19

21

ASA I / II

55.19 ± 8.95

33.75 ± 7.86

35

55.70 ± 7.87

34.95 ± 7.59

18

P

Weight (kg)

0.336 33.87 ± 7.03

28

Group T

158.86 ± 3.09 159.33 ± 4.54 158.02 ± 4.52 0.289 159.64 ± 6.13 159.35 ± 5.11 159.18 ± 4.64 0.933 158.67 ± 4.26 159.39 ± 4.35 159.33 ± 4.83 0.846

32.52 ± 6.30

40

Group F

Height (cm)

35.14 ± 8.28

45

Group C

34.02 ± 6.79

54

P

Age (years)

43

Group T

43

Group F

Cubital vein group

N

P

Group C

Group T

Group C

Group F

End of the radial vein group

Hand vein group

Table 1. Three groups of patients with different intravenous general information.
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79.95 ± 31.60

14.91 ± 6.50

2.00 / 2.00

16 / 15 / 8 / 1 / 2 / 1 13 / 16 / 7 / 3 / 1 / 2
23 / 4 / 11 / 3 / 2
25 / 11 / 4 / 2 / 1

Remifentanil (µg)

Duration of surgery
(min)

Recovery time to
discontinuation (min)

Respiratory depression
(SPO2 less than 90%)
Body movement

2.00 / 2.00

13.40 ± 5.86

62.25 ± 31.27

181.00 ± 55.14

186.86 ± 39.62

Propofol (mg)

43

43

N

10 / 27 / 12 / 3 / 2 / 0
32 / 5 / 9 / 4 / 4

2.00 / 2.00

13.50 ± 5.04

69.87 ± 27.80

183.41 ± 43.80

54

0.418
0.602

0.582

0.390

0.026

0.841

P

12 / 21 / 8 / 2 / 0 / 2
23 / 8 / 8 / 5 / 1

2.05 ± 1.49

15.64 ± 6.26

77.42 ± 33.62

184.24 ± 55.19

45

10 / 18 / 8 / 1 / 2 / 1
23 / 9 / 6 / 0 / 2

3.00 ± 2.32

14.28 ± 6.23

67.00 ± 34.27

196.68 ± 56.77

40

Group F

Group C

Group T

Group C

Group F

End of the radial vein group

Hand vein group

Table 3. Three groups of patients with different intravenous general information.

2 / 19 / 6 / 1 / 0 / 0
19 / 9 / 0 / 0 / 0

2.14 ± 1.27

13.46 ± 4.76

70.00 ± 27.42

161.96 ± 28.62

28

Group T

0.677
0.097

0.543

0.283

0.319

0.019

P

7/6/1/4/0/0
9/6/2/1/0

2.06 ± 1.26

14.50 ± 5.70

76.33 ± 31.33

178.67 ± 31.94

18

Group C

6 / 16 / 9 / 3 / 0 / 1
16 / 15 / 3 / 1 / 0

2.09 ± 1.49

14.31 ± 4.88

70.80 ± 30.60

185.20 ± 55.71

35

Group F

Cubital vein group

4/9/6/2/0/0
11 / 4 / 3 / 2 / 1

1.83 ± 1.20

11.71 ± 3.69

57.43 ± 17.13

166.95 ± 41.09

21

Group T

0.554
0.945

0.805

0.105

0.088

0.376

P

HUANG et al. / Turk J Med Sci

HUANG et al. / Turk J Med Sci
the groups (P = 0.001); pairwise comparison showed that
the incidence of dysphoria differed significantly between
Group C and Group T (χ2 = 8.629; P = 0.003 [<0.017]),
but that the remainder of the groups were not significantly
different in this regard (P > 0.017). The incidence of nausea
and vomiting differed significantly among the groups (P <
0.001); pairwise comparison showed that the incidence of
nausea and vomiting differed significantly between Group
C and Group T (P = 0.001 [<0.017]), as well as between
Group F and Group T (P = 0.000 [<0.017]), but that the
remainder of the groups showed no statistically significant
differences in this regard (P > 0.017).
In the “end of radial vein” subgroup, the incidence
of nausea and vomiting differed significantly among
the groups (P < 0.001); pairwise comparison showed
significant differences between Group C and Group T (P
= 0.016 [<0.017]). The difference between Group F and
Group T was also significant (P = 0.004 [<0.017]); however,
there was not a significant difference between Group C
and Group F in this regard (P = 0.535 > 0.017). In the
remaining variables, there were no significant differences
among the groups (Table 4).
Intravenous injection of additional propofol was
compared among the three groups using the four-point
scale, as well as incidence. In the hand vein subgroup,
the four-point scale did not differ significantly among the
groups (P = 0.050). The incidence of moderate-to-severe
pain did differ significantly (P = 0.003), as did the 1-h
postoperative visual analog scale (VAS) score (P = 0.003).
Pairwise comparison showed that Group C and Group
T differed significantly in this regard (P = 0.013), as did
Group F and Group T (P = 0.009).
In the “end of radial vein” subgroup, there were
significant differences among the groups in terms of the
four-point scale (P = 0.048). Pairwise comparison revealed
that Group T differed significantly from both Group C
and Group F (P = 0.037 and 0.021, respectively); Group C
and Group F did not differ significantly in this regard (P =
0.764). With regard to the incidence of moderate-to-severe
pain, there was a significant difference among the groups
(P = 0.012); pairwise comparison showed differences
in incidence between Group C and Group T (P = 0.007
< 0.017), as well as between Group F and Group T (P =
0.005 [<0.017]). Group C did not differ significantly from
Group F in this regard (P > 0.017). The 1-h postoperative
VAS score also differed significantly among the groups (P
< 0.001); pairwise comparison demonstrated that Group
T differed significantly from both Group C and Group
F in this regard (P = 0.012 and P < 0.001, respectively).
However, the difference between Group C and Group
T was not significant (P = 0.612), and there were no
significant differences in the other groups (P > 0.05).

In the cubital vein subgroup, there were significant
differences among the groups in terms of the four-point
scale (P < 0.05); pairwise comparison showed that the
four-point scale differed significantly between Group C
and both Group T and Group F (P = 0.016 and P = 0.001,
respectively). The incidences of pain and of moderate-tosevere pain difference differed significantly among the
groups (P < 0.05); pairwise comparison showed significant
differences between Group C and Group T (P = 0.005
[<0.017]). However, there was no significant difference
between Group C and Group T in this regard (P = 0.026
[>0.017]). There were no significant differences in the rest
of the group. The 1-h postoperative VAS scores differed
significantly among the groups (P = 0.013 [<0.05]);
pairwise comparison showed that it differed significantly
between Group F and Group T (P = 0.012 < 0.05). However,
the remaining variables showed no significant differences
in any group (Table 5).
4. Discussion
Propofol injection-related pain is associated with the
components of the formulation itself (7). Much preliminary
research has investigated the methods used to prevent or
relieve propofol injection-related pain; these methods
include nondrug approaches such as choosing a thicker
vein (8), slowing injection speed (9), dilution (10,11),
microfiltration (12), cooling the propofol (13), and topical
EMLA use (14), as well as drug interventions, such as
the use of lidocaine (15), opioids (16), sedatives (17,18),
muscle relaxants (19), and nonsteroidal antiinflammatories
(20,21), among others. A metaanalysis published in 2011
indicated that the most effective methods are selection of
a thicker vein and prophylactic preinjection of lidocaine
combined with vein occlusion (4). Selection of cubital
intravenous access can reduce the incidence of propofol
injection-related pain by 14%; however, this approach is
not the first clinical choice. Although other methods, such
as simple preinjection of lidocaine (22), have some effect,
no method or agent can completely prevent propofol
injection-related pain. Consequently, and for various other
reasons, the use of these methods is limited in clinical
practice. Although the mechanism of propofol injectionrelated pain remains unclear, one emerging hypothesis is
that contact between the propofol aqueous phase and the
vascular endothelium induces bradykinin release from the
kininase system, resulting in pain (23).
During TEAS, sparse waves induce encephalin and
endorphin release; they also act on δ receptors. In contrast,
density waves induce the release of a dimorphic response,
which acts on K receptors and causes an analgesic effect
(24). Not only does TEAS cause an analgesic effect, it also
reduces postoperative nausea and vomiting, as well as other
adverse reactions; these effects are related to the different
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0.017

0.155

0.129

P

5 / 18

1 / 18

2 / 18

18

Group C

43

3 / 19 / 17 / 5

3 / 40

22 / 21

19 / 19 / 5

N

The four-point (VRS)
(0 / 1 / 2 / 3)

0 / 1–3

0–1 / 2–3

VAS after 30 min
(VAS: 0 / 1 / 2)

17 / 24 / 2

24 / 19

2 / 41

1 / 22 / 16 / 4

43

39 / 13 / 2

44 / 10

0 / 54

5 / 34 / 12 / 3

54

0.003

0.003

0.123

0.050

P

19 / 23 / 3

27 / 18

4 / 41

4 / 23 / 14 / 4

45

11 / 26 / 3

23 / 17

4 / 36

4 / 19 / 11 / 6

40

Group F

Group C

Group T

Group C

Group F

End of the radial vein group

Hand vein group

22 / 5 / 1

25 / 3

2 / 26

2 / 23 / 3 / 0

28

Group T

11 / 7

0 / 18

0 / 11 / 7 / 0

18

Group C

<0.001 9 / 8 / 1

0.012

1.000

0.048

P

15 / 16 / 3

30 / 5

10 / 25

10 / 20 / 5 / 0

35

Group F

Cubital vein group

8 / 35

2 / 35

6 / 35

35

Group F

Cubital vein group

Table 5. The comparison of the intravenous injection of propofol by four-point method and incidence in three groups of patients.

43

N

P

Group C

Group T

Group C

Group F

End of the radial vein group

Hand vein group

Table 4. The comparison of restlessness, dysphoria, dizziness, nausea, and vomiting after surgery among three groups of patients.

18 / 2 / 1

20 / 1

9 / 12

9 / 11 / 1 / 0

21

Group T

0 / 21

4 / 21

0 / 21

21

Group T

0.013

0.027

0.008

0.001

P

0.019

0.255

0.124

P
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points selected. The present research selected one effective
analgesic acupuncture point—LI4-PC6—which has been
proven by both traditional acupuncture theory and clinical
experience of professional acupuncturists. Furthermore,
much research has been devoted to analgesic pain relief
(5,25), and PC6 acupuncture can significantly reduce the
incidence of postoperative nausea and vomiting. Some
research has specifically investigated the application of
TEAS in obstetrics and gynecology patients, and the
results have shown that not only can TEAS increase
the success rate of embryo transfer in infertile women
(26), it can also reduce the incidence of postoperative
nausea and vomiting after abdominal cavity laparoscopic
cholecystectomy procedures (27). In the present study, the
subjects were treated or examined with hysteroscopy.
On a different note, not only can the stimulation of
the LI4-PC6 acupoint achieve a certain analgesic effect,
it can also effectively improve postoperative nausea and
vomiting due to opioid use, hysteroscopy procedures, and
other causes. The results of the present study corroborated
this assertion.
Previous studies investigating propofol injectionrelated pain, other than research examining different vein
choice, have selected the largest hand vein as the infusion
channel. The present study examined three veins: the back
of the hand’s largest vein, the radial vein, and the elbow
vein. We chose this design because clinicians do not always
use a single hand as the maximum intravenous infusion
channel. In this regard, if the other two subgroups had
yielded similar results, our conclusion would have been
more convincing, as well as more suitable in the clinic.
When an indwelling intravenous needle was required, the
decision to use one was made by a nurse who was unaware
of the research. The patients were selected according to the
most appropriate intravenous approach in their specific
cases. The priority order was as follows: back of hand vein,
radial vein, cubital vein. Therefore, the sample sizes of the
three subgroups were not identical; the cubital vein group
was the smallest. Therefore, during the preliminary study
design, we accounted for the small sample size of a selected
group (statistical analysis cannot meet the condition); a
later sample was then added to increase the total sample
size and obviate problems related to small sample size.
In previous studies investigating the effects of drugs
on propofol injection-related pain, researchers did not
administer any sedatives or opioid analgesics other than
the test drug. In the present study, after 30 min of TEAS
pretreatment and before propofol injection, the patients

were routinely given 5 µg of sufentanil. The timing of
medication is very important in gynecological operations;
in this regard, pretrial test results showed that the incidence
of pain upon injection of propofol was not affected by the
administration of 5 µg of sufentanil 30 s before propofol
injection.
In the present study, the incidence of propofol injectionrelated pain was higher than that usually reported:
95.4% in the hand vein subgroup, 91.2% in the radial
vein subgroup, and as high as 100% in the cubital vein
subgroup. One reason for this phenomenon was that the
subjects in the present study were young women. Studies
have shown that young women exhibit factors that affect
the incidence of propofol injection-related pain (8,28).
Conversely, according to our hospital’s clinical habits, the
present study used 22-G intravenous catheters, while other
studies have used smaller sizes (18 G or 20 G). Propofol
was first administered through a 1-m-long extension tube
before reaching the body; in other studies, a Y-type direct
injection catheter has been used. Specifically, a study by
Wu et al. (29) examining the extension tube’s influence in
propofol injection-related pain reported that extending
the length of the propofol tube increases the concentration
of di-(2-ethylhexyl) phthalate in the patient’s body, as well
as the free propofol concentration, thereby increasing
propofol injection-related pain (29).
In conclusion, this study compared the incidence of
moderate-to-severe pain among three groups, indicating
that TEAS can effectively reduce the severity of propofol
injection-related pain. TEAS pretreatment can effectively
reduce the severity of propofol injection-related pain,
and, to a certain extent, it can reduce the incidence of
pain on injection. TEAS can also effectively reduce the
incidence of postoperative nausea and vomiting, as well as
postoperative pain scores.
A limitation of this study is that no other combination
of drugs and methods was used in to investigate better
ways of reducing the severity and the incidence of
injection-related pain. However, TEAS is a combination
of traditional and modern medicine. Not only can it
effectively reduce the severity and incidence of propofol
injection-related pain to some extent, it can also effectively
reduce the incidence of postoperative nausea and vomiting,
as well as postoperative pain scores. We hope that research
investigating the adjunctive use of TEAS leads to better
methods of reducing the incidence of injection-related
pain, and that it improves comfort during the entire
perioperative period.
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